TC
BLFS icon

Tarsadia Capital’s BioLife Solutions BLFS Stock Holding History

Tarsadia Capital’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-437,521
Closed -$7.15M – 30
2020
Q2 		$7.15M Sell
437,521
-40,000
-8% -$551K 1.27% 16
2020
Q1 		$4.54M Buy
+477,521
New +$6.56M 0.44% 18

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Tarsadia Capital's BLFS Position: Q3 2020 in Review

Tarsadia Capital sold out of BioLife Solutions (BLFS) in Q3 2020, closing a stake of 437,521 shares — an estimated $7.15M sold.

Tarsadia Capital first reported a position in BLFS in Q1 2020 and held it in 2 quarters. The position peaked at $7.15M in Q2 2020. 108 funds tracked by Wall St. Rank hold BLFS as of Q3 2020.

  • Tarsadia Capital reported no remaining BioLife Solutions position as of Q3 2020 after selling out during the quarter.
  • Tarsadia Capital sold 437,521 BioLife Solutions shares in Q3 2020, an estimated $7.15M.
  • Tarsadia Capital first reported a position in BioLife Solutions in Q1 2020 and held it in 2 quarters.
  • Tarsadia Capital's BioLife Solutions position peaked at $7.15M in Q2 2020.
  • 108 funds tracked by Wall St. Rank held BioLife Solutions as of Q3 2020.

Based on Tarsadia Capital's 13F filing for Q3 2020, filed 12 Nov 2020.